Medipha Santé

Medipha Santé is a French pharmaceutical company specializing in regulatory affairs, pharmacovigilance, and the commercialization of medicinal products. Founded in 2004 and acquired by Athena Pharmaceutiques in 2025, the company holds the status of exploitant and importer, enabling it to manage the entire lifecycle of pharmaceutical products in the French and European markets. Medipha Santé provides a comprehensive suite of services including marketing authorization applications, quality assurance, and distribution for over 100 international partners. Their product portfolio includes proprietary and generic medicines across therapeutic areas such as anesthesia, oncology, and cardiology.